Transition Bio Overview

  • Founded
  • 2020
Founded
  • Status
  • Private
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $9M
Latest Deal Amount
  • Investors
  • 1

Transition Bio General Information

Description

Operator of a biotechnology company dedicated to build a hypothesis-free drug discovery and diagnostics platform for human health care advancement. The company harnesses droplet microfluidic approaches and protein biophysics platforms to characterize condensates with unprecedented precision, thereby enabling medical practitioners to map condensates in molecular detail.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Cambridge, MA
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Transition Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 01-Sep-2020 $9M 000 0000 Completed Startup
To view Transition Bio’s complete valuation and funding history, request access »

Transition Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Transition Bio’s complete cap table history, request access »

Transition Bio Executive Team (2)

Name Title Board Seat Contact Info
David Weitz Ph.D Co-Founder and Board Member
Tuomas Knowles Ph.D Co-Founder and Board Member
To view Transition Bio’s complete executive team members history, request access »

Transition Bio Board Members (4)

Name Representing Role Since
David Weitz Ph.D Transition Bio Co-Founder and Board Member 000 0000
David Zimble Transition Bio Board Member 000 0000
Samuel Cohen Transition Bio Board Member 000 0000
Tuomas Knowles Ph.D Transition Bio Co-Founder and Board Member 000 0000
To view Transition Bio’s complete board members history, request access »

Transition Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Transition Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Lifeforce Capital Venture Capital Minority 000 0000 000000 0
To view Transition Bio’s complete investors history, request access »